Minerva Neurosciences (NERV) Tops Q2 EPS by 14c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.27), $0.14 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold